دورية أكاديمية
Antibody-drug conjugate targeting folate receptor α: a new milestone in personalized medicine for high-grade serous ovarian cancer.
العنوان: | Antibody-drug conjugate targeting folate receptor α: a new milestone in personalized medicine for high-grade serous ovarian cancer. |
---|---|
المؤلفون: | Gonzalez-Martin A; Medical Oncology Department, Cancer Center Clinica Universidad de Navarra, Madrid, Spain agonzalezma@unav.es. |
المصدر: | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Aug 05; Vol. 34 (8), pp. 1126-1127. Date of Electronic Publication: 2024 Aug 05. |
نوع المنشور: | Journal Article; Editorial |
اللغة: | English |
بيانات الدورية: | Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2019- : [London] : BMJ Original Publication: Cambridge, MA, USA : Blackwell Scientific Publications, c1991- |
مواضيع طبية MeSH: | Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/pathology , Precision Medicine*/methods , Immunoconjugates*/therapeutic use , Immunoconjugates*/administration & dosage , Folate Receptor 1*/antagonists & inhibitors, Humans ; Female ; Cystadenocarcinoma, Serous/drug therapy ; Cystadenocarcinoma, Serous/pathology |
مستخلص: | Competing Interests: Competing interests: None declared. |
فهرسة مساهمة: | Keywords: Ovary |
المشرفين على المادة: | 0 (Immunoconjugates) 0 (Folate Receptor 1) |
تواريخ الأحداث: | Date Created: 20240711 Date Completed: 20240805 Latest Revision: 20240805 |
رمز التحديث: | 20240806 |
DOI: | 10.1136/ijgc-2024-005861 |
PMID: | 38991657 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1525-1438 |
---|---|
DOI: | 10.1136/ijgc-2024-005861 |